Nick Kalivas of Invesco suggests a growth strategy that lowers investors’ risk from the S&P 500’s Big Tech concentration.

But a look at the most recent quarterly update shows it still has plenty of growth potential ahead. Revenue grew 16% year ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

So you've got $1,000 (or $10,000 or $50,000) burning a hole in your pocket -- and you want to invest in some growth stocks.

Wall Street's dramatic reaction to DeepSeek's AI announcement on Monday created compelling opportunities in unlikely places.

Wall Street analysts forecast the company will manage a 4.3% revenue increase in 2025, accompanied by a 1.5% rebound in EPS.

Apple's earnings call is today at 5 pm ET. AAPL stock heads into the report down 4% YTD. Analysts are focused on services and ...

Some of the most reliable millionaire-maker stocks are well-established companies with year after year of revenue growth and ...

The path to building lasting wealth through dividend investing requires identifying companies that combine sustainable payout ...

Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of Sysco Corp (NYSE:SYY) and lowered the price ...

To no one’s shock, analysts are expecting big things out of the semiconductor specialist. For the next fiscal year (2026), the Street is targeting revenue of $8.21 billion, almost 43% higher than ...

IBM (NYSE: IBM) stock has surged significantly in after-hours trading by 10% and 9% in pre-market trading. This is due to IBM reporting solid Q4 2024 results and bullish guidance for 2025. Here’s ...